VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

AACR 2021 | Chromosomal instability as a therapeutic target

Samuel F. Bakhoum, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, gives an overview of how deeper understanding of chromosomal instability improves mechanistic understanding of cancers, and how it may offer a novel therapeutic target which is selective for tumor-cells in the future. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.

Disclosures

Samuel F. Bakhoum, MD, PhD owns equity in, has received compensation from, has served as a consultant for and has served on the Scientific Advisory Board and the Board of Directors of Volastra Therapeutics Inc.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter